Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis

PLoS Neglected Tropical Diseases

Volumn 10, Issue 9, 2016, Pages

  Bustinduy, Amaya L ^a   Friedman, Jennifer F ^b   Kjetland, Eyrun Floerecke ^c,d   Ezeamama, Amara E ^e   Kabatereine, Narcis B ^f   Stothard, J Russell ^g   King, Charles H ^h  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b BROWN UNIVERSITY   (United States)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF GEORGIA   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ANEMIA; ARTICLE; BLEEDING; COGNITION ASSESSMENT; DRUG FORMULATION; HUMAN; LEARNING; MEMORY; NUTRITION; NUTRITIONAL DEFICIENCY; PAIN; PERFORMANCE; POINT OF CARE SYSTEM; PUBLICATION; SCHISTOSOMIASIS; WORLD HEALTH ORGANIZATION;

EID: 84991798788     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004946     Document Type: Article

References (25)

1. Colley DG, Bustinduy AL, Secor WE, King CH, Human schistosomiasis. Lancet. 2014. Epub 2014/04/05. doi: 10.1016/S0140-6736(13)61949-224698483.
2. Stothard JR, Sousa-Figueiredo JC, Betson M, Bustinduy A, Reinhard-Rupp J, Schistosomiasis in African infants and preschool children: let them now be treated!Trends Parasitol. 2013;29(4):197–205. doi: 10.1016/j.pt.2013.02.00123465781; PubMed Central PMCID: PMCPMC3878762.
3. Sousa-Figueiredo JC, Betson M, Atuhaire A, Arinaitwe M, Navaratnam AM, Kabatereine NB, et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis. 2012;6(10):e1864. Epub 2012/10/25. doi: 10.1371/journal.pntd.000186423094120; PubMed Central PMCID: PMC3475660.
4. World Health Organization. Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool-age children. Geneva: World Health Organization; 2011. vi, 23 p. p.
5. WHOSchistosomiasis: number of people treated worldwide in 2014. Weekly epidemiological record. 2016;5(91):53–60.
6. http://www.who.int/mediacenter/factsheets/fs115/en/ [cited 2016 15 July].
7. World Health OrganizationDivision of Child Health and DevelopmentUNICEFImproving child health: IMCI: the integrated approach. Geneva: World Health Organization; 1999. 21 p. p.
8. King CH, It's time to dispel the myth of "asymptomatic" schistosomiasis. PLoS Negl Trop Dis. 2015;9(2):e0003504. doi: 10.1371/journal.pntd.000350425695740; PubMed Central PMCID: PMCPMC4335065.
9. Albonico M, Allen H, Chitsulo L, Engels D, Gabrielli AF, Savioli L, Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy. PLoS Negl Trop Dis. 2008;2(3):e126. doi: 10.1371/journal.pntd.000012618365031; PubMed Central PMCID: PMCPMC2274864.
10. Bustinduy AL, Parraga IM, Thomas CL, Mungai PL, Mutuku F, Muchiri EM, et al. Impact of polyparasitic infections on anemia and undernutrition among Kenyan children living in a Schistosoma haematobium-endemic area. Am J Trop Med Hyg. 2013;88(3):433–40. doi: 10.4269/ajtmh.12-055223324217; PubMed Central PMCID: PMCPMC3592521.
11. Coutinho HM, Acosta LP, McGarvey ST, Jarilla B, Jiz M, Pablo A, et al. Nutritional status improves after treatment of schistosoma japonicum-infected children and adolescents. J Nutr. 2006;136(1):183–8. Epub 2005/12/21. 136/1/183 [pii]. 16365080.
12. Coutinho HM, Leenstra T, Acosta LP, Su L, Jarilla B, Jiz MA, et al. Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection. Am J Trop Med Hyg. 2006;75(4):720–6. 17038701.
13. Friedman JF, Kanzaria HK, McGarvey ST, Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol. 2005;21(8):386–92. 15967725.
14. Kjetland EF, Hegertun IE, Baay MF, Onsrud M, Ndhlovu PD, Taylor M, Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies. International journal of STD & AIDS. 2014;25(10):705–15. doi: 10.1177/095646241452374324621458.
15. Kjetland EF, Leutscher PD, Ndhlovu PD, A review of female genital schistosomiasis. Trends Parasitol. 2012;28(2):58–65. doi: 10.1016/j.pt.2011.10.00822245065.
16. Stecher CW, Kallestrup P, Kjetland EF, Vennervald B, Petersen E, Considering treatment of male genital schistosomiasis as a tool for future HIV prevention: a systematic review. International journal of public health. 2015;60(7):839–48. doi: 10.1007/s00038-015-0714-726298443.
17. Seto EY, Sousa-Figueiredo JC, Betson M, Byalero C, Kabatereine NB, Stothard JR, Patterns of intestinal schistosomiasis among mothers and young children from Lake Albert, Uganda: water contact and social networks inferred from wearable global positioning system dataloggers. Geospat Health. 2012;7(1):1–13. doi: 10.4081/gh.2012.9923242675.
18. Wami WM, Nausch N, Midzi N, Gwisai R, Mduluza T, Woolhouse M, et al. Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children. PLoS Negl Trop Dis. 2015;9(3). doi: 10.1371/journal.pntd.0003649. WOS:000352199400101.
19. Mutapi F, Rujeni N, Bourke C, Mitchell K, Appleby L, Nausch N, et al. Schistosoma haematobium treatment in 1–5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis. 2011;5(5):e1143. Epub 2011/05/26. doi: 10.1371/journal.pntd.000114321610855; PubMed Central PMCID: PMC3096601.
20. Mutapi F, Changing policy and practice in the control of pediatric schistosomiasis. Pediatrics. 2015;135(3):536–44. doi: 10.1542/peds.2014-318925687146.
21. Bustinduy A, Waterhouse D., de Sousa-Figueiredo J, Roberts S. A., Atuhaire A., Van Dam G.J, Corstjens PA., Scott JT., Stanton MC., Kabatereine NB., Ward S., Hope WH., Stothard JR., Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan children with Intestinal Schistosomiasis: Higher Dosages are Required for Maximal EfficacyMbio. 2016;In press: mBio 7(4):e00227–16. doi: 10.1128/mBio.00227-1627507822
22. consortium Pp. http://www.pediatricpraziquantelconsortium.org/what-we-do/pediatric-praziquantel-program.html 2016 [03/05/2016].
23. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M, Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 2012;9(9):e1001306. doi: 10.1371/journal.pmed.100130622973183; PubMed Central PMCID: PMCPMC3433407.
24. Pineiro Perez R, Santiago Garcia B, Fernandez Llamazares CM, Baquero Artigao F, Noguera Julian A, Mellado Pena MJ, et al. [The challenge of administering anti-tuberculosis treatment in infants and pre-school children. pTBred Magistral Project]. An Pediatr (Barc). 2016;85(1):4–12. doi: 10.1016/j.anpedi.2015.07.02726364849.
25. Lo NC, Bogoch II, Blackburn BG, Raso G, N'Goran EK, Coulibaly JT, et al. Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study. Lancet Glob Health. 2015;3(10):e629–38. doi: 10.1016/S2214-109X(15)00047-926385302.